Reports for TEVA CANADA LIMITED
Company Name
TEVA CANADA LIMITED
Totals |
||
Shortage reports |
2695 |
|
| Actual shortage: | 246 (9%) | |
| Anticipated shortage: | 0 (0%) | |
| Avoided shortage: | 9 (0%) | |
| Resolved: | 2440 (91%) | |
Discontinuation Reports |
250 |
|
| To be discontinued: | 3 (1%) | |
| Discontinued: | 247 (99%) | |
| Reversed: | 0 (0%) | |
Late reports |
330 (11%) |
|
Overdue reports |
26 (10%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| TEVA-SUMATRIPTAN | 100MG | TABLET | Resolved | 2021-06-24 | 2021-12-01 | 141483 |
| TEVA-SULINDAC | 150MG | TABLET | Resolved | 2021-06-24 | 2021-07-15 | 141486 |
| TEVA-TELMISARTAN HCTZ | 25.0MG 80.0MG | TABLET | Resolved | 2021-06-24 | 2022-01-20 | 141489 |
| ACT PRAMIPEXOLE | 0.25MG | TABLET | Resolved | 2021-07-08 | 2021-09-02 | 142172 |
| TEVA-ROPINIROLE | 1MG | TABLET | Resolved | 2021-07-08 | 2023-09-22 | 142175 |
| TEVA-ROPINIROLE | 2MG | TABLET | Resolved | 2021-07-08 | 2023-09-24 | 142178 |
| TEVA-EMTEC-30 | 30MG 300MG | TABLET | Resolved | 2021-07-08 | 2021-09-02 | 142183 |
| TEVA-BROMAZEPAM | 3MG | TABLET | Resolved | 2021-07-08 | 2021-09-09 | 142192 |
| TEVA-CYCLOBENZAPRINE | 10MG | TABLET | Resolved | 2021-07-08 | 2021-12-08 | 142195 |
| TEVA-SUMATRIPTAN DF | 100MG | TABLET | Resolved | 2021-07-08 | 2022-10-18 | 142201 |
| TEVA-VORICONAZOLE | 50MG | TABLET | Resolved | 2021-07-08 | 2021-08-24 | 142204 |
| TEVA-ATENOLOL | 50MG | TABLET | Resolved | 2021-07-08 | 2021-08-13 | 142207 |
| TEVA-CAPTOPRIL | 50MG | TABLET | Resolved | 2021-07-08 | 2021-07-16 | 142210 |
| ACT PRAMIPEXOLE | 0.25MG | TABLET | Avoided shortage | 2021-07-15 | 2021-07-15 | 142575 |
| TEVA-ROPINIROLE | 1MG | TABLET | Resolved | 2021-07-15 | 2021-07-15 | 142578 |
| TEVA-ROPINIROLE | 2MG | TABLET | Avoided shortage | 2021-07-15 | 2021-07-15 | 142581 |
| TEVA-ONDANSETRON | 8MG | TABLET | Resolved | 2021-07-15 | 2023-04-28 | 142604 |
| TEVA-ONDANSETRON | 4MG | TABLET | Resolved | 2021-07-15 | 2023-04-28 | 142607 |
| TEVA-BISOPROLOL | 5MG | TABLET | Resolved | 2021-07-15 | 2021-09-09 | 142616 |
| TEVA-CANDESARTAN | 16MG | TABLET | Resolved | 2021-07-15 | 2021-09-02 | 142619 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| ACT OXYCODONE CR | 80MG | TABLET (EXTENDED-RELEASE) | Discontinued | 2018-10-12 | 2018-10-12 | 63992 |
| ACT OXYCODONE CR | 5MG | TABLET (EXTENDED-RELEASE) | Discontinued | 2018-10-22 | 2018-10-22 | 65328 |
| ACT DONEPEZIL ODT | 10MG | TABLET (ORALLY DISINTEGRATING) | Discontinued | 2018-10-19 | 2018-10-19 | 64872 |
| ACT DONEPEZIL ODT | 5MG | TABLET (ORALLY DISINTEGRATING) | Discontinued | 2018-10-19 | 2018-10-19 | 64875 |
| ACT OLANZAPINE ODT | 5MG | TABLET (ORALLY DISINTEGRATING) | Discontinued | 2019-10-25 | 2019-10-26 | 97256 |
| ACT OLANZAPINE ODT | 15MG | TABLET (ORALLY DISINTEGRATING) | Discontinued | 2020-01-24 | 2020-01-24 | 104277 |
| TEVA-DEFERASIROX | 500MG | TABLET FOR SUSPENSION | Discontinued | 2019-10-25 | 2019-10-26 | 97248 |
| TEVA-DEFERASIROX | 500MG | TABLET FOR SUSPENSION | Discontinued | 2019-10-31 | 2019-11-01 | 97589 |
| TEVA-DEFERASIROX | 125MG | TABLET FOR SUSPENSION | Discontinued | 2020-01-21 | 2020-01-21 | 103791 |
| TEVA-DEFERASIROX | 250MG | TABLET FOR SUSPENSION | Discontinued | 2020-01-21 | 2020-01-21 | 103796 |